Tocilizumab increased sustained glucocorticoid-free remission from giant cell arteritis

Ann Intern Med. 2017 Dec 19;167(12):JC63. doi: 10.7326/ACPJC-2017-167-12-063.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Giant Cell Arteritis*
  • Glucocorticoids
  • Humans
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • tocilizumab